JAMA Medical News

Clinical Trials Disrupted During War in Ukraine; The Role of Supervised Consumption Sites for People Who Use Illicit Drugs Related Content: Clinical Trials Disrupted During War in Ukraine The Role of Supervised Consumption Sites for People Who Use Illicit Drugs

Preventive cardiologist and conference cochair Pamela Morris, MD, discusses new heart failure management guidelines and important clinical trial results presented at the American College of Cardiology's 2022 Scientific Sessions. Related Content: Highlights From the American College of Cardiology's Scientific Sessions—New Heart Failure Management Guidelines, Alirocumab After a Myocardial Infarction, and Treating Mild Chronic Hypertension in Pregnancy Short Interfering RNA Targeting Lp(a) Production in Individuals With Elevated Plasma Lp(a) Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis The Potential Clinical Benefit of Lowering Lipoprotein(a)

Physicians in Ukraine—Caring for Patients in the Middle of a War; The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks; How Cancer Will Affect the US in 2022 Related Content: Physicians in Ukraine: Caring for Patients in the Middle of a War The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks How Cancer Will Affect the US in 2022

Russian attacks on Ukraine have created a humanitarian crisis and made the treatment of patients exponentially more difficult. Two Ukrainian doctors, Oleksandra Shchebet and Anastasiia Barzylovych, share their experiences as they practice medicine in a dangerous wartime environment. Recorded March 9, 2022. Related Content: Physicians in Ukraine: Caring for Patients in the Middle of a War

JAMA Medical News Senior Staff Writer Melissa Suran speaks with Louise McCullough, MD, PhD, about new research and timely topics from the American Heart Association and American Stroke Association's annual International Stroke Conference. McCullough, who chaired this year's conference, is also chair of neurology at the University of Texas Health Science Center at Houston and chief of neurology at Memorial Hermann—Texas Medical Center. Related Content: Highlights From the International Stroke Conference 2022—Thrombectomy and Alteplase, Access to Stroke Centers, and Warfarin vs Direct Oral Anticoagulants

COVID-19 and the Common Cold: Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity; When Physicians Spread Unscientific Information About COVID-19; How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic. Related Content: COVID-19 and the Common Cold—Preexisting Coronavirus Antibodies May Hinder SARS-CoV-2 Immunity When Physicians Spread Unscientific Information About COVID-19 How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic

Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis; RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths; Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic." Related Content: Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic"

Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19; COVID-19 Vaccine Makers Plan for Annual Boosters, but It's Not Clear They'll Be Needed; Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19. Related Content: Thousands of US Youths Cope With the Trauma of Losing Parents to COVID-19 The Debate Over Whether Repeated COVID-19 Boosters Will Be Needed Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19

JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with physician-geneticist Francis S. Collins, MD, PhD, as he steps down as director of the National Institutes of Health (NIH) and returns full-time to his laboratory at the National Human Genome Research Institute. Collins discusses the NIH's biggest accomplishments and challenges during his historic tenure, shares what he will and won't miss about the job, and much more. Related Content: After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter

The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity, Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis, Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents. Related Article(s): The Flawed Science of Antibody Testing for SARS-CoV-2 Immunity Anti-SARS-CoV-2 Monoclonal Antibodies for Preexposure COVID-19 Prophylaxis Trials Test Mushrooms and Herbs as Anti–COVID-19 Agents